Tsubota Laboratory Incorporated (TYO:4890)
Japan · Delayed Price · Currency is JPY 227.00
+2.00 (0.89%)
Jun 4, 2026, 3:30 PM JST
Tsubota Laboratory Revenue
In the fiscal year ending March 31, 2026, Tsubota Laboratory had annual revenue of 200.00M JPY, down -85.26%. Tsubota Laboratory had revenue of 54.39M in the quarter ending March 31, 2026, a decrease of -90.37%.
Revenue
200.00M
Revenue Growth
-85.26%
P/S Ratio
29.28
Revenue / Employee
n/a
Employees
17
Market Cap
5.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 200.00M | -1.16B | -85.26% |
| Mar 31, 2025 | 1.36B | 684.00M | 101.63% |
| Mar 31, 2024 | 673.00M | -281.00M | -29.45% |
| Mar 31, 2023 | 954.00M | 314.00M | 49.06% |
| Mar 31, 2022 | 640.00M | -47.00M | -6.84% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ohki Healthcare Holdings | 360.36B |
| Qol Holdings | 290.77B |
| Cawachi | 284.49B |
| YAKUODO HOLDINGS | 163.81B |
| Medical System Network | 132.19B |
| Satudora Holdings | 100.36B |
| Pharmarise Holdings | 67.49B |
| Astena Holdings | 64.97B |